MedTrace Logo

To Study the Changes in Protein in Lung Cells of Asian Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

NCT01185314 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1270

Last updated 2011-08-08

No results posted yet for this study

Summary

The purpose of this study is to study the changes in protein in lung cells of Asian patients with advanced non small cell lung cancer.

Conditions

  • Non Small Cell Lung Cancer

Interventions

PROCEDURE

Testing for mutation status

EGFR mutation test

Sponsors & Collaborators

Principal Investigators

  • Guy Yeoman, MBBS, MFPM · AstraZeneca

  • Robin Meng, MD, PhD · AstraZeneca Taiwan

  • Yang Pan-Chyr, MD, PhD · National Taiwan University College of Medicine

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2011-07-31
Completion
2011-07-31

Countries

  • China
  • Hong Kong
  • India
  • Philippines
  • Taiwan
  • Thailand
  • Vietnam

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01185314 on ClinicalTrials.gov